Molecules (2018)
Update date:2022-09-26
Topics:
Cai, Wenqing
Wu, Jingwei
Liu, Wei
Xie, Yafei
Liu, Yuqiang
Zhang, Shuo
Xu, Weiren
Tang, Lida
Wang, Jianwu
Zhao, Guilong
In order to systematically explore and better understand the structure-activity relationship (SAR) of a diarylmethane backbone in the design of potent uric acid transporter 1 (URAT1) inhibitors, 33 compounds (1a-1x and 1ha-1hi) were designed and synthesized, and their in vitro URAT1 inhibitory activities (IC50) were determined. The three-round systematic SAR exploration led to the discovery of a highly potent novel URAT1 inhibitor, 1h, which was 200-and 8-fold more potent than parent lesinurad and benzbromarone, respectively (IC50 = 0.035 μM against human URAT1 for 1h vs. 7.18 μM and 0.28 μM for lesinurad and benzbromarone, respectively). Compound 1h is the most potent URAT1 inhibitor discovered in our laboratories so far and also comparable to the most potent ones currently under development in clinical trials. The present study demonstrates that the diarylmethane backbone represents a very promising molecular scaffold for the design of potent URAT1 inhibitors.
View MoreContact:0086-0573-85287218
Address:Room 301, Unit 2, Building 3, Alley 94, East Renmin Road, Pinghu City, Zhejiang Province, China
Shijiazhuang City Xiehe Pharmaceutical Co., Ltd
Contact:+86-311-80817929
Address:Shangzhuang,Shijiazhuang,China
Hangzhou Huarong Pharm Co., Ltd.
website:http://www.huarongpharm.com
Contact:+86-571-86758373
Address:Room1101, Hakim International Building, Gongshu District, Hangzhou, Zhejiang Province, China.
jiangsu haian chemical co.,ltd.
Contact:86-513-15851283853
Address:No.99,Changjiang West Road,Haian County,Jiangsu Province,China
Contact:
Address:
Doi:10.1080/00397911.2020.1802759
(2020)Doi:10.1016/j.bmc.2016.12.013
(2017)Doi:10.1021/om00046a012
(1992)Doi:10.1016/j.tetlet.2013.04.064
(2013)Doi:10.1021/om4000538
(2013)Doi:10.3762/bjoc.9.48
(2013)